Endpoint
Gestational hypertension incidence
CAT:outcome/gestational-hypertension-incidencereported in proportion1 finding from 1 compound
What moved it
How to read these marks1 finding · 1 compound · by evidence strength
| Compound | Direction | Findings | Strongest evidence |
|---|---|---|---|
| Ca(2+) | down | 1 | Evidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers. |
Reported to move it
1 finding
Ca(2+) — decreases
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Pooled analysis showed that calcium supplementation during pregnancy was associated with a significant reduction of 45% in risk of gestational hypertension [Relative risk (RR) 0.55; 95 % confidence interval (CI) 0.36-0.85] and 59% in the risk of pre-eclampsia [RR 0.41; 95 % CI 0.24-0.69] in developing countries.”
Quoted verbatim from Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries.. - Study
- meta-analysis
- Population
- Pregnant women in developing countries; pooled analysis of randomised controlled trials
Effect 0.55 risk ratio, 95% CI 0.36 to 0.85
Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries.2011PMID:21501435Permalink
How it is measured
Proportion of pregnant women with a new diagnosis of gestational hypertension, defined as blood pressure of 140/90 mmHg or above first arising after 20 weeks of gestation in a previously normotensive woman, without proteinuria. The diagnostic criteria set is recorded with each finding.
Sources cited
1 paper
- Subject
- gestational hypertension incidence
- Findings
- 1
- Papers
- 1